Literature DB >> 16242368

Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome.

Piroon Mootsikapun1, Sukanya Srikulbutr.   

Abstract

INTRODUCTION: Histoplasmosis and penicilliosis are infections caused by the dimorphic fungi, Histoplasma capsulatum and Penicillium marneffei, respectively. The aim of this study was to compare the clinical presentation, laboratory and radiologic findings and outcome of these infections at Srinagarind Hospital, Khon Kaen, Thailand.
METHODS: The medical records of patients who had positive cultures for Histoplasma capsulatum and Penicillium marneffei during 1996-2002 were reviewed. The data were compared and analyzed by the Chi-square and Fisher's exact tests.
RESULTS: There were 32 and 36 medical records of patients with H. capsulatum and P. marneffei infection, respectively, available for review. The most common underlying disease of patients with histoplasmosis and penicilliosis was acquired immunodeficiency syndrome (AIDS), which accounted for 90.6% and 91.7%, respectively. The most common clinical findings in both infections were fever, weight loss, cough, anemia, lymphadenopathy, hepatomegaly and splenomegaly. Frequencies of skin lesions were not statistically different between either group (P=0.20). Laboratory findings were similar between the two infections, except hyperbilirubinemia, which was more common in the penicilliosis group (P=0.02). There were similar abnormal X-ray findings in both groups with interstitial infiltration the most common abnormality.
CONCLUSIONS: Histoplasmosis and penicilliosis had similar clinical presentations, laboratory findings and chest X-ray abnormalities. Itraconazole is recommended as secondary prophylaxis in HIV-infected patients who have histoplasmosis or penicilliosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242368     DOI: 10.1016/j.ijid.2004.10.006

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis.

Authors:  Yan-Fang Wang; Jian-Piao Cai; Ya-Di Wang; Hui Dong; Wei Hao; Ling-Xiao Jiang; Jun Long; Cheman Chan; Patrick C Y Woo; Susanna K P Lau; Kwok-Yung Yuen; Xiao-Yan Che
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

3.  Treating progressive disseminated histoplasmosis in people living with HIV.

Authors:  Marylou Murray; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

4.  Bilateral adrenal histoplasmosis in an immunocompetent man from Texas.

Authors:  Colin J Rog; Daniel G Rosen; Francis H Gannon
Journal:  Med Mycol Case Rep       Date:  2016-11-29

5.  Disseminated histoplasmosis: a rare clinical phenotype with difficult diagnosis.

Authors:  Xiao-Feng Xiong; Li-Li Fan; Mei Kang; Jia Wei; De-Yun Cheng
Journal:  Respirol Case Rep       Date:  2017-02-26

Review 6.  Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report.

Authors:  Stephen K Field; Patricio Escalante; Dina A Fisher; Belinda Ireland; Richard S Irwin
Journal:  Chest       Date:  2017-11-28       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.